BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 17216042)

  • 1. Towards high-throughput characterization of small molecule mechanisms of action.
    Luesch H
    Mol Biosyst; 2006 Dec; 2(12):609-20. PubMed ID: 17216042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances and method development for drug target identification.
    Chan JN; Nislow C; Emili A
    Trends Pharmacol Sci; 2010 Feb; 31(2):82-8. PubMed ID: 20004028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics and proteomics in process development: opportunities and challenges.
    Gupta P; Lee KH
    Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein and small molecule microarrays: powerful tools for high-throughput proteomics.
    Uttamchandani M; Wang J; Yao SQ
    Mol Biosyst; 2006 Jan; 2(1):58-68. PubMed ID: 16880923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic methods for drug target discovery.
    Sleno L; Emili A
    Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array-based proteomics: high-throughput expression and purification of IMAGE consortium cDNA clones.
    Albala JS; Humphery-Smith I
    Curr Opin Mol Ther; 1999 Dec; 1(6):680-4. PubMed ID: 19629864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and genomic approaches to identify and study the targets of bioactive small molecules.
    Zheng XS; Chan TF; Zhou HH
    Chem Biol; 2004 May; 11(5):609-18. PubMed ID: 15157872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding the target after screening the phenotype.
    Hart CP
    Drug Discov Today; 2005 Apr; 10(7):513-9. PubMed ID: 15809197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data merging for integrated microarray and proteomic analysis.
    Waters KM; Pounds JG; Thrall BD
    Brief Funct Genomic Proteomic; 2006 Dec; 5(4):261-72. PubMed ID: 16772273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ATCG of drug discovery.
    Fernandes PB
    Curr Opin Mol Ther; 2000 Dec; 2(6):624-32. PubMed ID: 11249739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity-based proteomics: enzymatic activity profiling in complex proteomes.
    Schmidinger H; Hermetter A; Birner-Gruenberger R
    Amino Acids; 2006 Jun; 30(4):333-50. PubMed ID: 16773240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput target discovery using cell-based genetics.
    Jackson PD; Harrington JJ
    Drug Discov Today; 2005 Jan; 10(1):53-60. PubMed ID: 15676299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hit and lead generation: beyond high-throughput screening.
    Bleicher KH; Böhm HJ; Müller K; Alanine AI
    Nat Rev Drug Discov; 2003 May; 2(5):369-78. PubMed ID: 12750740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput gene expression profiling--a work-in-progress with great potential for proteomics.
    Roussel E; Gingras MC
    Curr Opin Drug Discov Devel; 2006 May; 9(3):332-8. PubMed ID: 16729729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cell-based genomic and small molecule screens.
    Caldwell JS
    Adv Cancer Res; 2007; 96():145-73. PubMed ID: 17161679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.